FDC Bromopride 10 mg and Simethicone 80 mg
DrugFixed-dose combination of Bromopride 10 mg and Simethicone 80 mg
Other names: Bromopride 10 mg and Simethicone 80 mg
NCT Number: NCT02604576
Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride on research participants diagnosed with functional dyspepsia.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 3
Centro de Medicina Reprodutiva Carlos Isaia Filho Ltda, Porto Alegre, Rio Grande do Sul, Brazil
Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride in the relief os dyspepsia symptoms on research participants diagnosed with functional dyspepsia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fixed-dose combination of Bromopride 10 mg and Simethicone 80 mg
Other names: Bromopride 10 mg and Simethicone 80 mg
Bromopride 10 mg
Other names: Digesan®
Time frame: 4 weeks
Time frame: 4 weeks
Safety assessment will be performed by evaluating the incidence of adverse events in each group as well as the relationship of these events to the drug used, the amount and severity of reported events.
EMS
Industry
Efficacy of Fixed-dose Combination of Bromopride and Simethicone Versus Isolated Bromopride in Participants With Functional Dyspepsia.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05810168
Digestive System Diseases, Dyspepsia
Sheffield, South Yorkshire, United Kingdom
View Trial DetailsNCT05004012
Digestive System Diseases, Dyspepsia
Los Angeles, California, United States
View Trial DetailsNCT06760897
Dysbiosis, Dyspepsia
Guangzhou, Guangdong, China
View Trial DetailsNCT06150638
Colonic Diseases, Colonic Diseases, Functional
Barcelona, Spain
View Trial Details